India  

Favipiravir

Experimental antiviral drug with potential activity against RNA viruses

Favipiravir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Favipiravir: Experimental antiviral drug with potential activity against RNA viruses
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.

0
shares
ShareTweetSavePostSend
 

You Might Like


Amid Covid surge, ICMR cautions on antibiotic use

The Indian Council of Medical Research has issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country. “The guideline does not advice the use of..
IndiaTimes - Published

FDC launches Favipiravir oral suspension to treat Covid-19 in India


IndiaTimes - Published

India welcomes 15 ventilators, 12000 tablets of Favipiravir from Iceland

India on early Wednesday received a consignment of 15 ventilators, and 12000 tablets of Favipiravir from Iceland as the country combat the second wave of Covid-19 pandemic.
IndiaTimes - Published

Vivimed gets DGHI nod to make, market Favipiravir


IndiaTimes - Published

Search this site and the web: